Member Login
  1. Stocks
    2. /
  2. Bellus Health (TSX: BLU)
    3. /

TSX:BLU (Bellus Health)

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bellus Health (TSX: BLU) Latest News

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Ambrose O'Callaghan

    Canadians on the hunt for growth should look to exciting biotech stocks like Fennec Pharmaceuticals Inc. (TSX:FRX) and others.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Brian Paradza, CFA

    Canadian biotech stock BELLUS Health has been snatched from the public market. However, these two biopharma growth stocks also have…

    Read more »

    Coronavirus

    TSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?

    | Amy Legate-Wolfe

    These healthcare stocks all offer different investment opportunities for investors, but which are the best buys on the TSX today?

    Read more »

    tsx today
    Stocks for Beginners

    TSX Today: What to Watch for in Stocks on Monday, April 24

    | Jitendra Parashar

    TSX investors will remain focused on corporate earnings this week.

    Read more »

    tsx today
    Stocks for Beginners

    TSX Today: Why Canadian Stocks Could Fall on Wednesday, April 19

    | Jitendra Parashar

    Steep intraday losses in commodity prices could pressurize the main TSX index at the open today.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    4 Biotech Stocks That Could Break Through the Market

    | Christopher Liew, CFA

    Four TSX biotech stocks could deliver outsized gains in 2023, as they are poised to break through the market soon.

    Read more »

    Investing

    2022’s Top Small Caps on the TSX: Are They Buys Today?

    | Daniel Da Costa

    These top small-caps were some of the few gainers on the TSX in 2022. But are these stocks worth buying…

    Read more »

    lab worker inspects test tubes
    Dividend Stocks

    3 Biotech Stocks to Buy Before the Down Market Is Over

    | Christopher Liew, CFA

    Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

    Read more »

    Investing

    2 Biotech Stocks to Buy Before the Down Market Recovers

    | Adam Othman

    While not all biotech stocks are trading at a discount, a holistic recovery is likely to push their prices higher.

    Read more »

    Dividend Stocks

    3 Growth Stocks You Can Buy Right Now with Less Than $100

    | Christopher Liew, CFA

    Capital of less than $100 is enough to buy one of these three promising growth stocks that don't belong to…

    Read more »

    Investing

    2 Best Healthcare Stocks to Buy Right Now

    | Brian Paradza, CFA

    BELLUS Health (TSX:BLU) is a Canadian biotech stock with promise. Income investors seeking juicy yields from healthcare stocks may look…

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    2 Top Healthcare Stocks Defying the Bear Market

    | Vishesh Raisinghani

    Healthcare stocks like Bellus Health (TSX:BLU) are defying the bear market.

    Read more »